Net Income (Loss) Attributable to Parent in USD of PSYCHEMEDICS CORP from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
PSYCHEMEDICS CORP quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q4 2024.
  • PSYCHEMEDICS CORP Net Income (Loss) Attributable to Parent for the quarter ending 31 Dec 2024 was $189,000.000.
  • PSYCHEMEDICS CORP Net Income (Loss) Attributable to Parent for the twelve months ending 31 Dec 2024 was -$1,861,000.000, a 55.2% increase year-over-year.
  • PSYCHEMEDICS CORP annual Net Income (Loss) Attributable to Parent for 2024 was -$1,861,000.000, a 55.2% increase from 2023.
  • PSYCHEMEDICS CORP annual Net Income (Loss) Attributable to Parent for 2023 was -$4,154,000.000, a 283% decline from 2022.
  • PSYCHEMEDICS CORP annual Net Income (Loss) Attributable to Parent for 2022 was -$1,084,000.000, a 63% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

PSYCHEMEDICS CORP Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$1,861,000 $189,000 +$1,134,000 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025
Q3 2024 -$2,995,000 -$535,000 +$1,564,000 +74.5% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 -$4,559,000 -$827,000 -$101,000 -13.9% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 -$4,458,000 -$688,000 -$304,000 -79.2% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024
Q4 2023 -$4,154,000 -$945,000 -$257,000 -37.4% 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025
Q3 2023 -$3,897,000 -$2,099,000 -$2,002,000 -20.6% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$1,895,000 -$726,000 -$388,000 -1.1% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$1,507,000 -$384,000 -$423,000 -10.8% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$1,084,000 -$688,000 +$933,000 +57.6% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 -$2,017,000 -$97,000 -$836,000 -1.1% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$1,181,000 -$338,000 -$472,000 -3.5% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$709,000 $39,000 -$44,000 -53% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$665,000 -$1,621,000 -$1,078,000 -2% 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023
Q3 2021 $413,000 $739,000 +$1,846,000 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$1,433,000 $134,000 +$2,184,000 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 -$3,617,000 $83,000 +$242,000 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 -$3,859,000 -$543,000 -$13,000 -2.5% 01 Oct 2020 31 Dec 2020 10-K 26 Mar 2021
Q3 2020 -$3,846,000 -$1,107,000 -$1,784,000 -2.6% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$2,062,000 -$2,050,000 -$2,818,000 -3.7% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $756,000 -$159,000 -$786,000 -1.3% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $1,542,000 -$530,000 -$1,411,000 -1.6% 01 Oct 2019 31 Dec 2019 10-K 26 Mar 2021
Q3 2019 $2,953,000 $677,000 -$598,000 -46.9% 01 Jul 2019 30 Sep 2019 10-K 26 Mar 2021
Q2 2019 $3,551,000 $768,000 -$409,000 -34.7% 01 Apr 2019 30 Jun 2019 10-K 26 Mar 2021
Q1 2019 $3,960,000 $627,000 -$624,000 -49.9% 01 Jan 2019 31 Mar 2019 10-K 26 Mar 2021
Q4 2018 $4,584,000 $881,000 -$1,469,000 -62.5% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2020
Q3 2018 $6,053,000 $1,275,000 -$89,000 -6.5% 01 Jul 2018 30 Sep 2018 10-K 25 Feb 2020
Q2 2018 $6,142,000 $1,177,000 +$270,000 +29.8% 01 Apr 2018 30 Jun 2018 10-K 25 Feb 2020
Q1 2018 $5,872,000 $1,251,000 -$249,000 -16.6% 01 Jan 2018 31 Mar 2018 10-K 25 Feb 2020
Q4 2017 $6,121,000 $2,350,000 -$10,000 -0.42% 01 Oct 2017 31 Dec 2017 10-K 04 Mar 2019
Q3 2017 $6,131,000 $1,364,000 -$1,344,000 -49.6% 01 Jul 2017 30 Sep 2017 10-K 04 Mar 2019
Q2 2017 $7,475,000 $907,000 -$726,000 -44.5% 01 Apr 2017 30 Jun 2017 10-K 04 Mar 2019
Q1 2017 $8,201,000 $1,500,000 +$1,523,000 01 Jan 2017 31 Mar 2017 10-K 04 Mar 2019
Q4 2016 $6,678,000 $2,360,000 +$2,175,000 +11.8% 01 Oct 2016 31 Dec 2016 10-K 16 Mar 2018
Q3 2016 $4,503,000 $2,708,000 +$1,912,000 +2.4% 01 Jul 2016 30 Sep 2016 10-K 16 Mar 2018
Q2 2016 $2,591,000 $1,633,000 +$1,381,000 +5.5% 01 Apr 2016 30 Jun 2016 10-K 16 Mar 2018
Q1 2016 $1,210,000 -$23,000 -$301,000 -1.1% 01 Jan 2016 31 Mar 2016 10-K 16 Mar 2018
Q4 2015 $1,511,000 $185,000 -$491,000 -72.6% 01 Oct 2015 31 Dec 2015 10-K 07 Mar 2017
Q3 2015 $2,002,000 $796,000 -$121,000 -13.2% 01 Jul 2015 30 Sep 2015 10-K 07 Mar 2017
Q2 2015 $2,123,000 $252,000 -$605,000 -70.6% 01 Apr 2015 30 Jun 2015 10-K 07 Mar 2017
Q1 2015 $2,728,000 $278,000 -$478,000 -63.2% 01 Jan 2015 31 Mar 2015 10-K 07 Mar 2017
Q4 2014 $3,206,000 $676,000 -$192,000 -22.1% 01 Oct 2014 31 Dec 2014 10-K 26 Feb 2016
Q3 2014 $3,398,000 $917,000 -$135,000 -12.8% 01 Jul 2014 30 Sep 2014 10-K 26 Feb 2016
Q2 2014 $3,533,000 $857,000 -$206,000 -19.4% 01 Apr 2014 30 Jun 2014 10-K 26 Feb 2016
Q1 2014 $3,739,000 $756,000 -$66,000 -8% 01 Jan 2014 31 Mar 2014 10-K 26 Feb 2016
Q4 2013 $3,805,000 $868,000 +$595,000 +2.2% 01 Oct 2013 31 Dec 2013 10-K 27 Feb 2015
Q3 2013 $3,210,000 $1,052,000 +$173,000 +19.7% 01 Jul 2013 30 Sep 2013 10-K 27 Feb 2015
Q2 2013 $3,037,000 $1,063,000 +$61,956 +6.2% 01 Apr 2013 30 Jun 2013 10-K 27 Feb 2015
Q1 2013 $2,975,044 $822,000 -$5,000 -0.6% 01 Jan 2013 31 Mar 2013 10-K 27 Feb 2015
Q4 2012 $2,980,044 $273,000 -$165,000 -37.7% 01 Oct 2012 31 Dec 2012 10-K 28 Feb 2014
Q3 2012 $3,145,044 $879,000 -$220,000 -20% 01 Jul 2012 30 Sep 2012 10-K 28 Feb 2014
Q2 2012 $3,365,044 $1,001,044 -$92,178 -8.4% 31 Mar 2012 30 Jun 2012 10-Q 14 Aug 2012
Q1 2012 $3,457,222 $827,000 -$31,000 -3.6% 01 Jan 2012 31 Mar 2012 10-K 28 Feb 2014
Q4 2011 $3,488,222 $438,000 01 Oct 2011 31 Dec 2011 10-K 08 Mar 2013
Q3 2011 $1,099,000 +$281,632 +34.5% 01 Jul 2011 30 Sep 2011 10-K 08 Mar 2013
Q2 2011 $1,093,222 +$220,282 +25.2% 31 Mar 2011 30 Jun 2011 10-Q 14 Aug 2012
Q1 2011 $858,000 01 Jan 2011 31 Mar 2011 10-K 08 Mar 2013
Q3 2010 $817,368 01 Jul 2010 30 Sep 2010 10-Q 04 Nov 2011
Q2 2010 $872,940 01 Apr 2010 30 Jun 2010 10-Q 16 Aug 2011

PSYCHEMEDICS CORP Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1,861,000 +$2,293,000 +55.2% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025
2023 -$4,154,000 -$3,070,000 -2.8% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025
2022 -$1,084,000 -$419,000 -63% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 -$665,000 +$3,194,000 +82.8% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023
2020 -$3,859,000 -$5,401,000 -3.5% 01 Jan 2020 31 Dec 2020 10-K 27 Mar 2023
2019 $1,542,000 -$3,042,000 -66.4% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022
2018 $4,584,000 -$1,537,000 -25.1% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2021
2017 $6,121,000 -$557,000 -8.3% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 $6,678,000 +$5,167,000 +3.4% 01 Jan 2016 31 Dec 2016 10-K 04 Mar 2019
2015 $1,511,000 -$1,695,000 -52.9% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
2014 $3,206,000 -$599,210 -15.7% 01 Jan 2014 31 Dec 2014 10-K 07 Mar 2017
2013 $3,805,210 +$825,581 +27.7% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016
2012 $2,979,629 -$509,654 -14.6% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015
2011 $3,489,283 +$875,563 +33.5% 01 Jan 2011 31 Dec 2011 10-K 28 Feb 2014
2010 $2,613,720 01 Jan 2010 31 Dec 2010 10-K 08 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.